Literature DB >> 2067638

Cervical dystonia: clinical findings and associated movement disorders.

J Jankovic1, S Leder, D Warner, K Schwartz.   

Abstract

We studied 300 patients, 61% women, with mean age 49.7 years and mean duration of dystonia 7.8 years, to determine the demographic and clinical characteristics of cervical dystonia (CD) and its relationships to other movement disorders. Torticollis was present in 82%, laterocollis in 42%, retrocollis in 29%, and anterocollis in 25%; however, the majority (66%) had a combination of these abnormal postures. Scoliosis was present in 39%, local pain reported by 68%, and 32% had evidence of secondary cervical radiculopathy. In addition to CD, 16% of patients had oral dystonia, 12% mandibular dystonia, 10% hand/arm dystonia, and 10% had blepharospasm. Tremor was noted in 71% of patients; head-neck tremor was present in 60%, and tremor in other body regions was present in 32%. A family history of a movement disorder was present in 44% of the CD patients. Tardive dystonia was the cause in 6%; 11% had posttraumatic dystonia. Anticholinergic drugs provided moderate improvement in 33% of patients, but local intramuscular botulinum toxin injections relieved CD, local pain, or both in over 90% of all treated patients.

Entities:  

Mesh:

Year:  1991        PMID: 2067638     DOI: 10.1212/wnl.41.7.1088

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  92 in total

1.  Oscillatory head movements in cervical dystonia: Dystonia, tremor, or both?

Authors:  Aasef G Shaikh; David S Zee; H A Jinnah
Journal:  Mov Disord       Date:  2015-04-16       Impact factor: 10.338

Review 2.  Rest tremor in dystonia: epidemiology, differential diagnosis, and pathophysiology.

Authors:  Navnika Gupta; Sanjay Pandey
Journal:  Neurol Sci       Date:  2020-04-23       Impact factor: 3.307

Review 3.  Botulinum toxin type A versus anticholinergics for cervical dystonia.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

4.  Abnormal activation of the motor cortical network in idiopathic scoliosis demonstrated by functional MRI.

Authors:  Julio Domenech; G García-Martí; L Martí-Bonmatí; C Barrios; J M Tormos; A Pascual-Leone
Journal:  Eur Spine J       Date:  2011-04-16       Impact factor: 3.134

Review 5.  The treatment of cervical dystonia with botulinum toxins.

Authors:  C L Comella
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

6.  Dr diaz, mr smith, and dr maccario respond.

Authors:  J M Diaz; K G Smith; M Maccario
Journal:  West J Med       Date:  1992-06

Review 7.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

8.  Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Authors:  Scott A Norris; H A Jinnah; Alberto J Espay; Christine Klein; Norbert Brüggemann; Richard L Barbano; Irene Andonia C Malaty; Ramon L Rodriguez; Marie Vidailhet; Emmanuel Roze; Stephen G Reich; Brian D Berman; Mark S LeDoux; Sarah Pirio Richardson; Pinky Agarwal; Zoltan Mari; William G Ondo; Ludy C Shih; Susan H Fox; Alfredo Berardelli; Claudia M Testa; Florence Ching-Fen Cheng; Daniel Truong; Fatta B Nahab; Tao Xie; Mark Hallett; Ami R Rosen; Laura J Wright; Joel S Perlmutter
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

9.  Familial adolescent-onset scoliosis and later segmental dystonia in an Irish family.

Authors:  Sean O'Riordan; Timothy Lynch; Michael Hutchinson
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Pallidal Activity in Cervical Dystonia with and Without Head Tremor.

Authors:  Alexey Sedov; Svetlana Usova; Ulia Semenova; Anna Gamaleya; Alexey Tomskiy; Sinem B Beylergil; H A Jinnah; Aasef G Shaikh
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.